NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
Publication
, Journal Article
Ettinger, DS; Wood, DE; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; D'Amico, TA; Dilling, TJ; Dowell, J ...
Published in: J Natl Compr Canc Netw
March 2, 2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2, 2021
Volume
19
Issue
3
Start / End Page
254 / 266
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., … Hughes, M. (2021). NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw, 19(3), 254–266. https://doi.org/10.6004/jnccn.2021.0013
Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.” J Natl Compr Canc Netw 19, no. 3 (March 2, 2021): 254–66. https://doi.org/10.6004/jnccn.2021.0013.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021 Mar 2;19(3):254–66.
Ettinger, David S., et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.” J Natl Compr Canc Netw, vol. 19, no. 3, Mar. 2021, pp. 254–66. Pubmed, doi:10.6004/jnccn.2021.0013.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dowell J, Gettinger S, Gubens MA, Hegde A, Hennon M, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW, Lovly CM, Martins RG, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Riely GJ, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Yanagawa J, Yang SC, Gregory KM, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021 Mar 2;19(3):254–266.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
March 2, 2021
Volume
19
Issue
3
Start / End Page
254 / 266
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis